Enfusion, Inc.
ENFN
ENFN was delisted on the 17th of April, 2025.
101 hedge funds and large institutions have $774M invested in Enfusion, Inc. in 2024 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 48 increasing their positions, 16 reducing their positions, and 16 closing their positions.
8,060% more call options, than puts
Call options by funds: $408K | Put options by funds: $5K
200% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 16
50% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 16
6% more funds holding
Funds holding: 95 → 101 (+6)
5% less capital invested
Capital invested by funds: $811M → $774M (-$37.7M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LECM
Lead Edge Capital Management
New York
|
+$8.09M |
| 2 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$5.99M |
| 3 |
Impax Asset Management Group
London,
United Kingdom
|
+$4.94M |
| 4 |
BlackRock
New York
|
+$4.64M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$4.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$12.8M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$7.33M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.34M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.52M |
| 5 |
CC
Clearline Capital
New York
|
-$647K |
ENFN Hedge Fund Activity: Q2 2024 in Review
101 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q2 2024, worth a combined $774M — down 4.6% from $811M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new ENFN positions and 16 closed out — a net gain of 8 holders — while 48 added to existing stakes and 16 trimmed.
The largest buyer was Lead Edge Capital Management, adding an estimated $8.09M. The largest seller was Brown Capital Management, cutting an estimated $12.8M.
- 101 institutional investors held Enfusion, Inc. (ENFN) as of Q2 2024, up from 95 in Q1 2024.
- Funds reported $774M of Enfusion, Inc. stock for Q2 2024, down 4.6% quarter-over-quarter.
- 24 funds opened new Enfusion, Inc. positions in Q2 2024 and 16 closed out, a net change of +8 holders.
- The largest Enfusion, Inc. buyer in Q2 2024 was Lead Edge Capital Management, an estimated $8.09M added.
- The largest Enfusion, Inc. seller in Q2 2024 was Brown Capital Management, an estimated $12.8M sold.
Based on aggregated 13F filings for Q2 2024.